Berman Capital Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$35K Buy
286
+9
+3% +$1.16K 0.01% 812
2021
Q2
$33K Buy
277
+18
+7% +$2.06K 0.01% 743
2021
Q1
$27K Buy
259
+40
+18% +$4.06K 0.01% 694
2020
Q4
$22K Buy
219
+5
+2% +$470 0.01% 649
2020
Q3
$18K Hold
214
0.01% 633
2020
Q2
$13K Buy
214
+104
+95% +$6.86K ﹤0.01% 678
2020
Q1
$6K Buy
110
+77
+233% +$6.07K ﹤0.01% 858
2019
Q4
$2K Hold
33
﹤0.01% 1263
2019
Q3
$2K Hold
33
﹤0.01% 1244
2019
Q2
$2K Hold
33
﹤0.01% 1248
2019
Q1
$2K Hold
33
﹤0.01% 1142
2018
Q4
$2K Buy
+33
New +$2.28K ﹤0.01% 916

Other funds holding XYL

Berman Capital Advisors's XYL Position: Q3 2021 in Review

Berman Capital Advisors increased its Xylem (XYL) stake by 3.2% in Q3 2021, buying an estimated $1.16K and bringing the position to 286 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #812.

Berman Capital Advisors first reported a position in XYL in Q4 2018 and has held it in 12 quarters since. 784 funds tracked by Wall St. Rank hold XYL as of Q3 2021.

  • Berman Capital Advisors held 286 shares of Xylem worth $35K as of Q3 2021.
  • Berman Capital Advisors bought 9 Xylem shares in Q3 2021, an estimated $1.16K.
  • Xylem made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #812 holding.
  • Berman Capital Advisors first reported a position in Xylem in Q4 2018 and has held it in 12 quarters since.
  • 784 funds tracked by Wall St. Rank held Xylem as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.